16:50 - 17:20 Ján Kyselovič, Faculty of Pharmacy, Comenius University in Bratislava, Impact of patient medication on the cells therapy
16:20 - 16:50 Daniel Smrž, Institute of Immunology, 2nd Medical School and University Hospital Motol, Charles University,
Cytoskeleton rearrangement in human mast cells – a new role for stem cell factor in mast cell anaphylactic responses
15:50 - 16:20 Coffee Break
15:30 - 15:50 Marie Kalbáčová, Institute of Inherited Metabolic Disorders , Charles University in Prague, First Faculty of Medicine
Cryopreservation of cells under FBS-free conditions
15:00 - 15:30 Čestmír Altaner, Institute of Experimental Oncology, Slovak Academy of Sciences
Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells 14:45 - 15:00 Ján Vojtaššák, Institute of Medical Biology, Genetics and Clinical Genetics, School of Medicine, Bratislava
The use of Autologous Mesenchymal Stem Cells for Bone Augmentation in Orofacial Surgery
12:45 - 14:45 Lunch + Poster Section 12:00 - 12:45 Sylvie Bailly, Corning
Corning’s innovative solutions for production of advanced therapy medicinal products (ATPM)
11:30 - 12:00 Eva Matějková, National Tissue Centre Inc. Issues in Advanced Therapy Medicinal Product Development 11:00 - 11:30 Coffee Break
10:30 - 11:00 Radek Špíšek, SOTIO, Charles University,
2nd Medical School and University Hospital Motol, Department of Immunology Dendritic cell-based immunotherapy of the prostate cancer
09:45 - 10:30 Vladimír Holáň, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, v.v.i.,
Stem cells in ocular surface reconstruction
09:15 - 09:45 Tomáš Soukup, Department of Histology and Embryology, Faculty of Medicine in Hradec Králové, Charles University
SYMBIOSIS: Assistive Devices and Mesenchymal Stem Cells 09:00 - 09:15 Ondrej Držík, BARIA s.r.o.
Úvodní slovo
čtvrtek 24.10.2013
PROGRAM:
11:30 - 12:00 Discussion
11:00 - 11:30 Lucie Kučerová, Miroslava Matúšková, Cancer research institute, Slovak academy of sciences
MSC and Cancer - Two Sides of One Coin 10:30 - 11:00 Coffee Break
10:00 - 10:30 Bernd Leistler, Cellgenix, Media and Cytokines for Ex Vivo Cell Culture
09:30 - 10:00 Jan Motlík, Institute of animal physiology and genetics, Academy of Sciences of the Czech Republic, v.v.i.
Transgenic minipigs for the N-terminal part of human huntingtin: a biomedical model of neurodegenerative diseases
09:00 - 09:30 Robert Dobrovolný, Institute of Inherited Metabolic Disorders , Charles University in Prague, First Faculty of Medicine
Induced pluripotent stem cells as a cellular model for inborn errors of metabolism 2. část - pátek 25.10.2013
POSTEROVÁ SEKCE:
Role of HIF-1- in selfrenew and differentiation of neurospheres derived from embryonic stem cells
Pánská V.1,Večeřa J.1, Kubala L.2,3, Pacherník J.1,3
Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic1
Institute of Biophysics ASCR v.v.i., Brno, Czech Republic2 ICRC - CBCE, FNUSA, Brno, Czech3
The role of ATP-binding transporters associated with multi-drug resistance in stem cells
Lánová M., Večeřa J., Kučera J., Procházková J., Pacherník J. Přírodovědecká fakulta Masarykovy univerzity
Recruitment of Oct4 protein to UV-damaged chromatin in embryonic stem cells
Bártová E., Stixová L., Franek M., Kozubek S., Legartová S. Biofyzikální ústav AV ČR
Surface antigen CD26 as a marker for purification of CML stem cells
Borský M., Némethová V., Rázga F., Mayer J., Ráčil Z. Fakultní nemocnice Brno
A novel tool for induction of specific T cell immune responses: Complexes
of streptavidin-fused antigen with biotinylated antibodies targeting endocytic receptors of antigen presenting cells
Staněk O., Majlessi L., Linhartová I., Leclerc C., Šebo P. Mikrobiologický ústav, AV ČR, v.v.i.
Expression of the stem cell marker nestin in leukemia cells
Loja T.1,2, Borský M.1, Bernard T.1, Doubek M.1,2
Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Czech Republic1
CEITEC – Central European Institute of Technology, Masaryk University, Czech Republic2
Mitochondrial Morphology in Cultured Cells with Mutation in TMEM70 gene
Sládková J.1, Kratochvílová H.1, Rodinova M.1, Chernyavskiy O.2, Čapek M.2, Radochová B.2
Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague1
Department of Biomathematics, Institute of Physiology Academy of Sciences of the Czech Republic2
Institute of Cellular Biology and Pathology 1st Faculty of Medicine, Charles University Prague, Czech Republic L.3
A mouse model of Fabry disease: Utilization of induced pluripotent stem cells
to obtain disease relevant cell types (cardiomyocytes)
Rybová J., Dobrovolný R., Ledvinová J. Ústav dědičných metabolických poruch
Haematopoiesis in vitro under HIF-1 modulation
Hanáčková M., Štefková K., Kubala L., Pacherník J. Masaryk University, Faculty of Science
Cell adhesion and further cell fate on different carbon materials in the presence or absence of fetal bovine serum
Verdánová M., Brož A., Rezek B., Ukraintsev E., Kromka A., Babchenko O., Kalbáčová M.
Ústav dědičných metabolických poruch 1.LF UK a VFN v Praze
Hematopoiesis of mouse embryonic stem cells - the role of p38alpha kinase
Štefková K., Hanáčková M., Kučera J., Kubala L., Pacherník J. Masaryk University
Exposure of colon cancer-derived HT-29 cells to 5-Fluorouracil alters their response to chemotherapeutics and MSC-mediated enzyme/prodrug treatment
Ďuriníková E., Kozovská Z., Kučerová L., Matúšková M. Ústav experimentálnej onkológie SAV
Prodrug gene therapy mediated by mesenchymal stem cells leads to complete regression of glioblastoma in a preclinical study
Cihova M., Altanerova V., Altaner C., Mravec B., Ondicova K. Ústav experimentálnej onkológie SAV
